Ceridian HCM Stock Forecast, Price & News

Ceridian HCM (NYSE:CDAY) Frequently Asked Questions

Is Ceridian HCM a buy right now?

10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Ceridian HCM in the last year. There are currently 1 sell rating, 4 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Ceridian HCM stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CDAY, but not buy additional shares or sell existing shares.
View analyst ratings for Ceridian HCM or view top-rated stocks.

What stocks does MarketBeat like better than Ceridian HCM?

Wall Street analysts have given Ceridian HCM a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Ceridian HCM wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Ceridian HCM's next earnings date?

Ceridian HCM is scheduled to release its next quarterly earnings announcement on Thursday, November 4th 2021.
View our earnings forecast for Ceridian HCM.

How were Ceridian HCM's earnings last quarter?

Ceridian HCM Holding Inc. (NYSE:CDAY) released its earnings results on Wednesday, August, 4th. The company reported $0.06 earnings per share for the quarter, beating the consensus estimate of $0.03 by $0.03. The firm earned $250.40 million during the quarter, compared to analysts' expectations of $238.48 million. Ceridian HCM had a negative net margin of 6.92% and a negative trailing twelve-month return on equity of 1.15%. The company's quarterly revenue was up 30.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.13 earnings per share.
View Ceridian HCM's earnings history.

How has Ceridian HCM's stock been impacted by COVID-19?

Ceridian HCM's stock was trading at $56.63 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, CDAY shares have increased by 99.4% and is now trading at $112.94.
View which stocks have been most impacted by COVID-19.

What guidance has Ceridian HCM issued on next quarter's earnings?

Ceridian HCM issued an update on its FY 2021 earnings guidance on Wednesday, September, 1st. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.01 billion-$1.02 billion, compared to the consensus revenue estimate of $1 billion.

What price target have analysts set for CDAY?

10 brokerages have issued 12 month target prices for Ceridian HCM's stock. Their forecasts range from $87.00 to $120.00. On average, they anticipate Ceridian HCM's share price to reach $106.33 in the next twelve months. This suggests that the stock has a possible downside of 5.8%.
View analysts' price targets for Ceridian HCM or view top-rated stocks among Wall Street analysts.

Who are Ceridian HCM's key executives?

Ceridian HCM's management team includes the following people:

• David D. Ossip, Chairman & Chief Executive Officer
• Leagh E. Turner, President & Chief Operating Officer
• Noemie C. Heuland, Chief Financial Officer & Executive Vice President
• Joe Korngiebel, Chief Product & Technology Officer, Executive VP
• William Everett McDonald, Secretary, General Counsel & Executive VP

What is David Ossip's approval rating as Ceridian HCM's CEO?

902 employees have rated Ceridian HCM CEO David Ossip on Glassdoor.com. David Ossip has an approval rating of 92% among Ceridian HCM's employees. This puts David Ossip in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Ceridian HCM's key competitors?

Some companies that are related to Ceridian HCM include Autodesk (ADSK), Twilio (TWLO), CrowdStrike (CRWD), VMware (VMW), Activision Blizzard (ATVI), Atlassian (TEAM), Palantir Technologies (PLTR), NetEase (NTES), DocuSign (DOCU), Synopsys (SNPS), Veeva Systems (VEEV), Datadog (DDOG), Cadence Design Systems (CDNS), Roblox (RBLX) and Cloudflare (NET).
View all of CDAY's competitors.

What other stocks do shareholders of Ceridian HCM own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ceridian HCM investors own include Workday (WDAY), Advanced Micro Devices (AMD), Alibaba Group (BABA), NVIDIA (NVDA), Adobe (ADBE), Alteryx (AYX), Costco Wholesale (COST), ServiceNow (NOW), Paycom Software (PAYC) and Tesla (TSLA).

When did Ceridian HCM IPO?

(CDAY) raised $420 million in an initial public offering (IPO) on Thursday, April 26th 2018. The company issued 21,000,000 shares at $19.00-$21.00 per share. Goldman Sachs, J.P. Morgan, Credit Suisse and Deutsche Bank Securities acted as the underwriters for the IPO and Barclays, Citigroup, Jefferies, CIBC Capital Markets, Wells Fargo Securities, Baird, Canaccord Genuity, Piper Jaffray, William Blair and MUFG were co-managers.

What is Ceridian HCM's stock symbol?

Ceridian HCM trades on the New York Stock Exchange (NYSE) under the ticker symbol "CDAY."

Who are Ceridian HCM's major shareholders?

Ceridian HCM's stock is owned by many different institutional and retail investors. Top institutional shareholders include Price T Rowe Associates Inc. MD (13.40%), Vanguard Group Inc. (8.49%), BlackRock Inc. (8.14%), Cannae Holdings Inc. (8.01%), JPMorgan Chase & Co. (4.10%) and FMR LLC (3.15%). Company insiders that own Ceridian HCM stock include Arthur Gitajn, Cannae Holdings, Inc, Christopher R Armstrong, David D Ossip, Gerald C Throop, Jeffrey Scott Jacobs, Leagh Erin Turner, Lisa M Sterling, Scott A Kitching and Thomas H Lee Advisors, Llc.
View institutional ownership trends for Ceridian HCM.

Which major investors are selling Ceridian HCM stock?

CDAY stock was sold by a variety of institutional investors in the last quarter, including Cannae Holdings Inc., BlackRock Inc., Putnam Investments LLC, Price T Rowe Associates Inc. MD, Millennium Management LLC, Nuveen Asset Management LLC, Russell Investments Group Ltd., and Northern Trust Corp. Company insiders that have sold Ceridian HCM company stock in the last year include Christopher R Armstrong, David D Ossip, Gerald C Throop, Jeffrey Scott Jacobs, and Leagh Erin Turner.
View insider buying and selling activity for Ceridian HCM or view top insider-selling stocks.

Which major investors are buying Ceridian HCM stock?

CDAY stock was purchased by a variety of institutional investors in the last quarter, including FMR LLC, JPMorgan Chase & Co., State Street Corp, Deutsche Bank AG, Echo Street Capital Management LLC, Artisan Partners Limited Partnership, Citigroup Inc., and Amalgamated Bank.
View insider buying and selling activity for Ceridian HCM or or view top insider-buying stocks.

How do I buy shares of Ceridian HCM?

Shares of CDAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Ceridian HCM's stock price today?

One share of CDAY stock can currently be purchased for approximately $112.94.

How much money does Ceridian HCM make?

Ceridian HCM has a market capitalization of $16.93 billion and generates $842.50 million in revenue each year. The company earns $-4,000,000.00 in net income (profit) each year or $0.14 on an earnings per share basis.

How many employees does Ceridian HCM have?

Ceridian HCM employs 5,974 workers across the globe.

What is Ceridian HCM's official website?

The official website for Ceridian HCM is www.ceridian.com.

Where are Ceridian HCM's headquarters?

Ceridian HCM is headquartered at 3311 EAST OLD SHAKOPEE ROAD, MINNEAPOLIS MN, 55425.

How can I contact Ceridian HCM?

Ceridian HCM's mailing address is 3311 EAST OLD SHAKOPEE ROAD, MINNEAPOLIS MN, 55425. The company can be reached via phone at (952) 853-8100 or via email at [email protected].